Abstract:Purpose The purpose of this paper is to examine the factors affecting profitability of pharmaceutical company in Indonesia. While research and development has been the main discussed issues in pharmaceutical sector development, scant attention has been paid to profitability factors determined by financial ratio specifically. The industry itself faces significant disruption with the implementation of universal health coverage in Indonesia. This study investigates the factors affecting profitability in an Indonesian pharmaceutical company after the national health insurance policy implementation. Design/methodology/approach This research is based on five independent variables (IVs) with six measurements that were empirically examined for their relationship with profitability. These variables are firm size (as measured by total sales), company efficiency (assets turnover), liquidity (current ratio), market power (the Lerner index) and a firm's growth (as measured by sales growth and sustainable growth rate). Data of ten pharmaceutical companies listed on the Indonesia Stock Exchange covering the period of 2014–2018 were extracted from companies' annual reports. Pooled ordinary least squares regression and fixed effects were used to analyze the data. Findings The findings show strong and positive relationships between liquidity and sustainable growth rate with profitability as measured by return on equity (ROE), return on assets (ROA) and earning per share (EPS), except EPS for liquidity. Further, both firm size and market power show positive significant relationships with ROA but negative significant relationships with EPS. Sales growth and company efficiency (as measured by assets turnover ratio) have no significant relationship with profitability. Research limitations/implications Due to data availability, the data include only listed pharmaceutical companies in the Indonesia Stock Exchange. Practical implications These results benefit internal users (such as managers, shareholders and employees). They can realize the determinants of enhancing the profitability of their company after the implementation of universal health coverage from the Indonesian government (JKN – Jaminan Kesehatan Nasional) since 2014. On the other side, other external users (such as investors, creditors, newly established pharmaceutical companies and tax authorities) also may get advantages of these results. It is clear that a significant impact happened upon this new policy implementation, and how an Indonesian pharmaceutical company will be profitable in the future. The relevance of company's business strategy (product and customer portfolio, competitor intelligence, etc.) with the profitability factors from this study can be further scrutinized as further consideration for both internal and external users. Originality/value This study differs from previous studies in many ways; first, it focuses on pharmaceutical companies in Indonesia. Previous studies have concentrated on different countries and companies in other sectors, such as services, banking and financial institutions or on industrial organizations. Second, this study analyzes the data from pharmaceutical companies' annual reports since 2014. There was a significant event of universal health coverage (national health insurance) implementation from the Indonesian government. Third, the study used ROE, ROA and EPS as indicators of profitability. Last but not least, the results of the study provide empirical evidence that firms with significant market power, good liquidity and well-managed sustainable growth rate improve operating income and ultimately enhance profitability.

Pengaruh Modal Kerja terhadap Profitabilitas Perusahaan pada Sektor Kesehatan di Indonesia

The Effect of Covid-19 on Working Capital Strategy and Profitability

Pengaruh manajemen modal kerja terhadap profitabilitas perusahaan fast moving consumer goods di Indonesia dari tahun 2016-2021

Do Firms Change the Working Capital Management Policy During The Covid-19 Pandemic? Case of Transportation & Logistics and Healthcare Industries in Indonesia

Pengaruh struktur modal, ukuran perusahaan, dan perencanaan pajak terhadap profitabilitas

FACTORS AFFECTING PROFIT MANAGEMENT IN THE HEALTHCARE SECTOR LISTED ON THE INDONESIAN STOCK EXCHANGE

The Effect of Profitability, Asset Structure, Business Risk, and Liquidity on Capital Structure in Health Sector Companies Listed on the Indonesia Stock Exchange

Determinants of Profitability in Pharmaceutical and Health Sector Companies in Indonesia Stock Exchange

Does Working Capital Management Impact Profitability? A Study on ASEAN-5 Food and Beverage Companies

Factors affecting profitability of pharmaceutical company: an Indonesian evidence

Analysis Of Factors Affecting The Profitability In Consumer Goods Sector Companies Listed On The Indonesia Stock Exchange In 2015-2020 Period

ANALYSIS OF PROFITABILITY, WORKING CAPITAL, INVENTORY BEFORE AND AFTER THE COVID-19 PANDEMIC: EMPIRICAL STUDY FROM THE PHARMACEUTICAL INDUSTRY

EFFECT OF WORKING CAPITAL MANAGEMENT, SALES GROWTH AND LIQUIDITY ON PROFITABILITY IN MANUFACTURING COMPANIES LISTED ON THE INDONESIA STOCK EXCHANGE (IDX) FOR THE PERIOD 2018-2020

Factors Affecting The Profitability Of Property And Real Estate Companies In Indonesia

ANALYSIS OF THE FINANCIAL PERFORMANCE OF FOOD AND BEVERAGE COMPANIES BEFORE AND DURING THE COVID-19 PANDEMIC IN INDONESIA

THE EFFECT OF RISK MANAGEMENT IMPLEMENTATION ON RETURN ON ASSETS OF INDONESIAN CONVENTIONAL COMMERCIAL BANKS AFTER THE COVID 19 PANDEMIC IN THE DIGITAL ECONOMY ERA

Impact of the Covid 19 Pandemic on the Financial Performance of Consumer Goods Industry in 2019-2020 on the Indonesia Stock Exchange

Factors Affecting Profit Quality in Post Pandemic Era

Pengaruh Penerapan Green Accounting, Material Flow Cost Accounting, dan Environmental Performance terhadap Profitabilitas Perusahaan

Company's Financial Performance Before and During the Covid-19 Pandemic on the Indonesia Stock Exchange

The Effect Covid-19 and Sectoral Financing on Islamic Bank Profitability in Indonesia